Quince Therapeutics IRLA
Quince Therapeutics: additional proxy materials
- Form
- DEFA14A
- Filed
- Importance
- Routine
- Accession
- 0001193125-26-182267
Not explained yet; the original is on EDGAR.
Additional proxy materials
Similar companies
Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.
- Veru VERU public float $64M, Mar 31, 2025, over 18 months old
- Lifevantage LFVN public float $64M, Dec 31, 2025
- Whitehawk Therapeutics WHWK public float $65M, Jun 30, 2025
- Medicinova MNOV public float $62M, Jun 30, 2025
- Corbus Pharmaceuticals Holdings CRBP public float $68M, Jun 30, 2025
